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Summary
A large family of tissue-specific nuclear proteins interact
with the octamer motif ATTTGCAT, a transcriptional
regulatory element found in the promoter and enhancer
sequences of many genes. As a step towards elucidating
the mechanism of this regulation, cDNA clones of the
mouse Oct2 protein were isolated. One, called here
Oct2b, encodes a larger variant of the previously de-
scribed Oct2a proteins. The Oct2b cDNA has an inser-
tion of 74 bp close to the 3' end which creates an open
reading frame distinct from Oct2a. As a result, the
Oct2b protein has a carboxy end which is similar to that
of the ubiquitous octamer-binding protein Octl. Analy-
sis of the Oct2 gene shows that Oct2a and Oct2b are
differentially spliced products of the same gene. The
insertion in the Oct2b cDNA results from the inclusion of
an additional exon in the mRNA which would otherwise
reside in an intron sequence of the Oct2a transcript.
RNA analysis demonstrates that both Oct2a and 2b
mRNAs are most abundant in B-cells but they are also
expressed in a variety of tissues including brain, intes-
tine, testis, kidney, as well as in embryos. Interestingly,
the ratio of Oct2a and 2b varies among tissues. In situ
hybridization studies during mouse embryogenesis show
that the Oct2 gene is widely expressed in the developing
nervous system. In contrast, expression in the adult
brain is confined to very specific areas which include the
suprachiasmatic and medial mammillary nuclei, hippo-
campus, olfactory tract and the olfactory bulb. Oct2
proteins are present in both neuronal and oligodendro-
glial cells, although they are more abundant in glial cells.
Key words: octamer, Oct2b protein, DNA-binding proteins,
Oct2 gene, differential splicing, embryogenesis.
Introduction
The octamer motif, ATTTGCAT, is a transcriptional
regulatory element found in the promoter and enhancer
sequences of many genes (Falkner and Zachau, 1984;
Parslow et al. 1984; Bergman et al. 1984; Ares et al.
1985; Mattaj et al. 1985; Mason etal. 1985; Mangin etal.
1986; Carbon et al. 1987; for a review see Hatzopoulos
et al. 1988). The octamer is necessary and sufficient for
B-lymphocyte-specific expression of the immunoglobu-
lin genes (Wirth etal. 1987; Lenardo etal. 1987; Gerster
et al. 1987). Moreover, the octamer is also found in the
regulatory region of genes that are not lymphoid-
specific, including the thymidine kinase gene (Parslow
et al. 1987), the snRNA genes (Carbon et al. 1987) and
the histone H2b gene (LaBella et al. 1988).
Previously, two proteins have been described that
interact with the octamer motif (Singh et al. 1986;
Landolfi et al. 1986; Staudt et al. 1986; Rosales et al.
1987; Scheidereit e/a/. 1987). One called Octl (alsoNF-
Al, NFII1, OBP100 or OTF-1) is ubiquitously ex-
pressed and is involved in the cell-cycle regulation of
the histone H2b gene (Fletcher et al. 1987; Sturm et al.
1988a), in adenovirus DNA replication (Prujin et al.
1986; Rosenfeld et al. 1987) and in the expression of the
snRNA genes (Ares et al. 1985; Mattaj et al. 1985;
Mangin et al. 1986; Carbon et al. 1987; Tanaka et al.
1988). The second, Oct2 (also NF-A2 or OTF-2), was
originally thought to be present only in B-cells (Lan-
dolfi et al. 1986; Staudt et al. 1986) and, as such,
responsible for the lymphocyte-specific expression of
the immunoglobulin genes. Recently, both Octl and
Oct2 proteins have been purified and their respective
cDNAs have been isolated and characterized (Sturm et
al. 1987; Fletcher et al. 1987; O'Neil and Kelly, 1988;
Scheidereit et al. 1987; Sturm et al. 19886; Staudt et al.
1988; Ko et al. 1988; Miiller et al. 1988; Scheidereit et al.
1988; Clerc et al. 1988). The two sequences share
extensive homology in the area responsible for DNA
binding called the POU-domain (Herr et al. 1988),
which is also found in other genes (Bodner et al. 1988;
Ingraham et al. 1988; Finney et al. 1988). Part of this
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region shows similarity to the homeobox, a conserved
sequence originally found in many Drosophila genes
involved in development (Gehring, 1987). During re-
cent years, a large number of mammalian genes con-
taining homeobox sequences have been isolated (for a
review and references see Dressier and Gruss, 1988).
Their expression during embryogenesis suggests of a
role in pattern formation; however, their exact function
is unknown even though they can interact with specific
DNA sequences (Odenwald et al. 1989). The cloning of
Octl and Oct2 shows that the homeodomain is a DNA-
binding structure employed not only by developmen-
tally regulated genes but also by genes involved in
tissue-specific gene expression.
In addition to Octl and Oct2, another lymphoid-
specific factor known as OTF-2B has been described
(Schreiber et al. 1988), as well as a testis-specific one
(Barberis et al. 1987), a factor present in F9 embryonic
carcinoma cells termed NF-A3 (Lenardo et al. 1989)
and a factor present in melanoma cells (Cox et al. 1988).
Recently, we have shown that a family of proteins,
termed Octl to OctlO, interact with the octamer motif
raising the possibility that a large set of genes is
regulated by distinct octamer-binding proteins in a
tissue-specific manner (Scholer et al. 1989a).
An important finding of our previous study was that
Oct2-like complexes are also present in nuclear extracts
of brain, kidney, mouse day 12 embryo and sperm
(Scholer et al. 1989a). These results raised several
interesting questions. Are the Oct2-like complexes due
to the presence of the Oct2 protein in the tissues
mentioned above, or to a distinct protein that fortui-
tously has the same mobility shift? In case of the first
possibility, where is Oct2 expressed during embryogen-
esis and what is its role? Are the large number of
octamer binding proteins, the products of distinct genes
as it appears to be the case for Octl and Oct2 or are
some of these due to differential splicing of the same
gene?
In order to answer these questions, we isolated
mouse cDNA sequences from B-cells encoding the
murine equivalent of Oct2 (or OTF-2 or NF-A2), here
called Oct2a (see below). Using this as a probe, it is
shown that Oct2a is expressed in a wide variety of
tissues including brain, kidney, intestine, testis as well
as in mouse day 12 embryos.
In addition to cDNA clones encoding Oct2a, a
second class of cDNAs was isolated, called Oct2b, that
showed two differences from Oct2a. The first difference
is a deletion of 48 bases (16 amino acids) upstream from
the P0£/-domain. This deletion is also found in some
human Oct2a clones (Scheidereit et al. 1988). The
second is an insertion of 74 bases at an area after the
homeobox and close to the 3' end. This insertion
creates a distinct longer open reading frame which
results in a completely different carboxy terminus.
Interestingly, this new carboxy end is very similar to the
corresponding area of Octl indicating that they might
have similar functions.
Initial characterization of the mouse Oct2 gene shows
that the 48 base deletion in Oct2b results from the use of
a downstream splice acceptor site, while the 74 base
insertion is due to the splice of an additional exon found
in the intron sequences of the nuclear Oct2a transcript.
The Oct2b cDNA was transcribed in vitro, translated
in reticulocyte lysates and used in the electrophoresis
mobility shift assay. The results suggest that this cDNA
encodes the previously identified OTF-2B protein (pre-
dicted Mr 75X103; Schreiber et al. 1988). Oct2b, which
was also thought to be lymphoid specific, is expressed in
the same tissues as Oct2a, although the ratio of Oct2a to
Oct2b varies among tissues.
In situ hybridization in day 12 embryos shows that the
Oct2 gene is expressed mainly throughout the develop-
ing nervous system, i.e. the neural tube, diencephalon,
mesencephalon, metencephalon and myelencephalon.
In contrast, expression in the adult brain is confined to a
limited number of areas, which include the medial
mammillary and suprachiasmatic nuclei, the CA1-CA4
areas of the hippocampus, the olfactory bulb and the
olfactory tract. By separating neuronal and oligoden-
droglial nuclei and preparing nuclear extracts, it is
shown that Oct2a protein is found in both cell types but
is more abundant in glial cells.
Materials and methods
Isolation of cDNA and chromosomal clones
The mouse B-cell lymphoblastoid cDNA library in Agtll
(Clontech) and the mouse C57 chromosomal library in
AEMBL3 (kindly provided by Dr Kenji Imai) were screened
with chemically synthesized oligonucleotides of the homeo-
box sequence of the human Oct2 (Ko et al. 1988; Miiller et al.
1988; Scheidereit et al. 1988; Clerc et al. 1988). Two single-
stranded 90 bases long oligonucleotides were synthesized
covering the entire 180 bases of the coding strand of the
homeobox sequence. Two 12 nucleotides long primers were
also made and used to produce radioactive non-coding strand
probes by the Klenow fragment of DNA polymerase. After
plating the libraries, denatured phage DNA was transferred
to Hybond-N filters (Amersham) and hybridized under low-
stringency conditions (6xSSC, 60°C). The filters were washed
two times in 2xSSC, 0.1 % SDS at room temperature and two
times at 42°C. Positive plaques were isolated, phages were
grown and phage DNA was purified according to standard
procedures (Maniatis et al. 1982). cDNA clones were named
mRl to mR5 and chromosomal clones mCRl to mCR4. The
two different Oct2 transcripts are referred in the text as
mOct2a and mOct2b while the protein products and the
protein-DNA complexes in the EMSA as Oct2a and Oct2b.
Subcloning and sequencing
The cDNA inserts of Agtll clones mR2 and mR4 were cloned
into the plasmid vector Bluescript (Stratagene) and mapped
with various restriction enzymes (plasmids pi.2 and p2.2,
respectively). In addition, the 2.2 kb insert of clone mR4
(sequence in Fig. 1) was divided in two fragments by using the
Hind\\\ single restriction site at position 1342. The resulting
1.3 and 0.9 kb fragments were cloned in Bluescript (plasmids
pK and pL, respectively). Similarly, the 1.2 kb insert of clone
mR2 was divided by Hin&lll into two fragments of 0.62 kb (5'
part) and 0.58 kb (3' part) long and cloned in Bluescript
(plasmids pF and pE, respectively). The 385bp fragment of
mR4 from the Sad site at position 1590 to the Nael site at
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position 1975 in Fig. 1 was also subcloned in Bluescript
(plasmid pN). Fragments K, L, E and F were cloned into M13
in both orientations and sequenced with the dideoxy method
(Sanger et al. 1977) using both deazaGTP and dJTP nucleo-
tides and chemically synthesized internal primers (Sequenase
Kit from US Biochemical). Various chromosomal fragments
covering the area that hybridized with the cDNA inserts were
also subcloned in Bluescript and sequenced directly using the
dideoxy method (Sanger et al. 1977).
RNA isolation and RNase protection analysis
Female NMRI outbred mice were mated overnight and the
day of the vaginal plug was noted as day 0. Embryos were
dissected free of extraembryonic tissue and frozen in liquid
nitrogen.'RNA was isolated by homogenizing mouse day 12
embryos and tissues of adult mice in 5 M guanidinium thiocya-
nate, 50 mM Tris-HCl pH7.5, 10 mM Na2EDTA pH8.0 and
5 % v/v /S-mercaptoethanol (Chirgwin et al. 1979) and centri-
fuged for lOmin at 10000 revs min"1. 1/10 vol of 20%
Sarkosyl was added to the supernatant and the samples were
heated at 65°C for 3min. 0.1 gml"' CsCl was added and
samples were centrifuged through a 5.7 M CsCl, 100 mM
Na2EDTA pH8.0 cushion in a Beckman SW28 rotor spun at
25 000 revs min"1 at 18°C overnight. The RNA pellets were
redissolved in 3 ml 5mM Na2EDTA pH8.0, 0.5% Sarkosyl
and 5% /J-mercaptoethanol. After phenol-chloroform-iso-
amyl alcohol (25:24:1) extractions, the RNA was precipitated
by addition of 1/10 vol 3 M sodium acetate pH 5.2 and 2.5 vol
ethanol. For the RNase protection experiments, plasmids pF
and pN were linearized using the BamHl site within the
Bluescript polylinker and the radioactively labelled antisense
strand was synthesized by T3 polymerase. After phenol-
chloroform-isoamyl alcohol (25:24:1) extraction and two
ethanol precipitations, the probes were dissolved in 80%
formamide, 20mM Pipes pH6.4, 400mM NaCl, lmM
Na2EDTA pH8.0. RNA pellets (4-40 mg) were also dis-
solved in 30 i^l of the same buffer and 1 /*1 of probe
(100000-500000cts min"1) was added. The samples were
heated for 10 min at 85°C and subsequently hybridization was
carried overnight at 65°C. Next day, the samples were treated
with 0.7 jig RNase A and 70 units RNase Tl for one hour at
37°C in 350/il 10 mM Tris-HCl pH7.5, 5mM EDTA, 300 mM
NaCl. Subsequently, 50 ^g proteinase K and 20//1 10% SDS
were added and reactions carried for 15 min. (All three
enzymes were from Boehringer Mannheim). After phenol-
chloroform-isoamyl alcohol (25:24:1) extraction and ethanol
precipitation, the products were separated in 6% denaturing
polyacrylamide gels. The gels were dried and autoradio-
graphed.
Northern analysis
Total or poly (A)+ was denatured at 68°C, separated on a
1.2% agarose-formaldehyde gel and blotted onto Hybond N
(Amersham) using IOXSSC. Prehybridization was carried out
at 42°C in 50% formamide, 6xSSC, 5xDenhardt's, 0.1%
SDS and 100 jig ml"1 denatured salmon sperm DNA for 4h.
Hybridization was carried out under the same conditions for
12 h in the presence of the 32P-labelled probe (lxlO6
ctsmin"'). The filters were washed twice in 2xSSC, 0.1%
SDS at room temperature for 20 min, followed by two washes
of 10 min at 60°C in 0.2XSSC and 0.1% SDS and exposed to
Kodak XAR film for 3 days.
In situ hybridization
Plasmid pF was linearized and single-stranded RNA probes
were transcribed in vitro using 100 mCi 35S-UTP and T3 or T7
polymerases (Promega Biotech.). After DNase digestion,
probes were precipitated with 10% trichloroacetic acid and
collected on nitrocellulose filters (Millipore). Probes were
eluted from the filters in 50 mM EDTA pH8.0, 0.1 % SDS at
65°C. Following ethanol precipitation, probes were partially
degraded with 0.2 N NaOH on ice for 30-60 min and neutral-
ized with 1M acetic acid. After ethanol precipitation, the
probes were resuspended in 50% formamide, 10 mM DTT.
Sections (8/tm) were prepared and hybridized as described
(Hogan et al. 1986; Dony and Gruss, 1987). Sections were cut
in a cryostat and transferred onto subbed slides. The sections
were dried at 55 °C, fixed in 4 % paraformaldehyde (PFA) and
dehydrated in graded ethanol. Slides were kept at -20°C until
the day of hybridization. Slides were dipped in distilled water
and incubated at 70°C in 2xSSC (standard saline citrate).
After a second rinse with distilled water, slides were digested
with 0.125 mg ml"1 pronase for 10 min at room temperature
and the digestion was stopped in 0.2 % glycine for 30s. Slides
were rinsed in PBS and refixed in 4% PFA for 20 min and
rinsed again in PBS. Slides were acetylated in 0.1 M triethano-
lamine with 1/400 volume acetic anhydride, made fresh.
Slides were rinsed again in PBS and dehydraded in graded
ethanol. After prolonged air drying, the hybridization mix-
ture was added. The probe was diluted to approximately
5xl04ctsml~L in a buffer containing 50% formamide,
2xSSC, 10mM Tris, 10mM NaPO4 pH6.8, 5mM EDTA, 10%
dextran sulphate, IOITIM DTT, and 150j/gmr' tRNA,
150 ftgrnP1 denatured salmon sperm DNA, 0.1 mM UTP,
10^M S-ATP, lmM ADP/SS and lOmM /J-mercaptoethanol.
The hybridization mix was boiled for 2 min, applied directly
onto sections and covered with a siliconized cover slip.
Hybridization was done overnight in a humid chamber at
50°C. The slides were washed for 3-4 h in 50% formamide,
2xSSC and 10mM ^-mercaptoethanol at 37°C followed by
RNase digestion. A second wash in 50 % formamide, 2xSSC,
10 mM /J-mercaptoethanol was done overnight and the slides
were then dehydrated in graded ethanol. Slides were dipped
in Kodak NTB-2 emulsion diluted 1:1 with water and allowed
to dry in a dark chamber for 2-3 h.
Slides were placed in a dark plastic box, wrapped in foil and
allowed to expose for 7-20 days at 4°C. Development was
done at room temperature for 3 min in Kodak D-19, followed
by 30 s in 1% acetic acid and 3 min in 30% sodium thiosul-
phate. After repeated washes in distilled water, the mouse
embryo day 12 slides were stained with Giemsa and allowed to
dry. The adult mouse brain sections were stained with 0.5 %
toluidine blue in 10 mM sodium acetate pH4.6 for 10 min,
quickly rinsed in distilled water and then dehydrated in
acetone, acetone: xylene (1:1) and xylene for 5 min each.
Photomicrographs were taken with a Leitz Labovert bright-
field/dark-field microscope.
Nuclear extract preparation and electrophoretic
mobility shift assay (EMSA)
Nuclear extracts were prepared as described before (Dignam
et al. 1983; Scholer et al. 1989a). The separation of neuronal
and glial nuclei was carried essentially as previously described
(Stoykova et al. 1979). Binding conditions and electrophoresis
were as described in Scholer et al. 1989a. The DNA fragment
harbouring the octamer motif (Gerster et al. 1987, termed 1W
in SchOler et al. 1989a) contains the region 518-564 of the
immunoglobulin heavy chain enhancer except at position 562
(numbering according to Ephrussi et al. 1985).
In vitro transcription and translation
Plasmid p2.2 was linearized using the BamHl and Sail
restrictions sites in the Bluescript polylinker and the sense and
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antisense RNA strands were synthesized with the T3 and T7
RNA (Promega) polymerases, respectively. The reaction
conditions were 40 rain Tris-HCl pH8.0, 8mM MgCl2, 25 mM
NaCl, 2mM spermidine, 5mM DTT, 2mM NTPs, 2mM
m7G(5')ppp5'G, 7j.ig template and 2 /.tl enzyme. 1/50 of the
RNA template was translated in a rabbit reticulocyte lysate
following the manufacturer's specifications (BRL). 1/6 of the
translation mix was used in the EMSA as described above.
Results
Isolation of mouse Oct2a and Oct2b clones
Two single-stranded 90 nucleotides long fragments
spanning the entire homeobox area of the human Oct2
sequence (Ko etal. 1988; Miiller etal. 1988; Scheidereit
et al. 1988; Clerc et al. 1988) were synthesized, radioac-
tively labelled and used as probes to screen a mouse
B-cell Agtll cDNA library. Five clones were isolated
called mRl to mR5. The insert size ranged from 1 to
3.5 kb. Two clones, mR2 (1.2kb) and mR4 (2.2kb)
were selected for further characterization. Sequence
analysis showed that the mR2 insert coded for an
incomplete sequence at the 5' end of the mouse Oct2
gene, here called mOct2a (see below). The sequence of
the mR4 insert showed that it is also a mouse Oct2
clone, but when it was compared to mOct2a and the
published human sequences (Ko et al. 1988; Miiller et
al. 1988; Scheidereit et al. 1988; Clerc et al. 1988) two
differences emerged. Therefore, this sequence was
tentatively named mOct2b. The first difference is a
deletion of 48 bp upstream of the POU-domain at the
end of the glutamine-rich region which removes 16
amino acids from the protein product (Fig. 1). This
deletion was also present in one of the human Oct2a
clones (Scheidereit etal. 1988). The second difference is
an insertion of 74 bp close to the 3'end of the human
and mouse Oct2a, at 37 bp upstream from the stop
codon (Fig. 1). Since the 74bp does not cause an in
frame insertion, a new open reading frame is created.
As a result, the last 12 amino acids of Oct2a are not
present and instead 132 new residues are added before a
new stop codon is encountered.
When the human and mouse sequences are com-
pared, they show a high degree of homology. Most base
changes are occuring in the third position of the codon.
Consequently, only a few amino acid substitutions
occur between human and mouse sequences (Fig. 1).
None of the amino acid substitutions are located within
the POU-domain, which is required for DNA binding
(Sturm and Herr, 1988).
The predicted protein sequence is also shown in
Fig. 1. Upstream of the methionine assigned as position
1, multiple stop codons are found in all three reading
frames. Methionines are found at positions 6 and 13.
The first two, 1 and 6, match well the optimal AUG
context (Kozak, 1986), but at this point it is unclear
which one is actually used. Moreover, at the 3' end no
typical poly (A) tail is found indicating that the clones
were produced by internal priming in an A-rich area of
the message.
The carboxy ends of Oct2b and Octl are simifor
The 132 new amino acids in the carboxy end of Oct2b
are mainly serines-threonines (28%), alanines (15%),
leucines-isoleucines (15 %), glycines (13.6 %) and pro-
lines (9.8%) with very few charged amino acids. This
carboxy terminus of Oct2b shows extensive similarity to
the carboxy end of Octl. Computer homology plots
show that, besides the extensive homology found in the
area of the POU-domain, this is a second area that the
two sequences are very homologous. In Fig. 2 the last
133 amino acids of Oct2b are aligned with the last 128
amino acids of Octl. The homology to Octl starts
within the insertion at amino acid 457 and extends into
the Oct2b open reading frame. This similarity suggests
that the carboxy terminal domains of the two proteins
may have similar functions.
Clone mR4 encodes a distinct protein
The open reading frame of clone mR4 encodes for a
protein that is 103 amino acids longer than Oct2a or 119
amino acids longer than the Oct2a variant with the 16
residues deletion (Scheidereit et al. 1988). Since Oct2a
runs with an apparent Mr of around 60X103 (Scheider-
eit et al. 1987; Miiller et al. 1988), the new clone would
appear as a 70-75xlO3 protein. Recently a new
octamer-binding factor called OTF-2B present in cer-
tain B-cell lines has been identified (Schreiber et al.
1988). The predicted Mr of this protein is 75X103
suggesting that mOct2b might encode OTF-2B. To
confirm this, the mR4 insert was excised and cloned in
the plasmid vector Bluescript. Using the T3 and T7
polymerases the 'sense' (coding) and 'antisense' (non-
Fig. 1. Sequence of mouse Oct2b. The 2191 nucleotides of
the entire insert of Agtll clone mR4 is shown as mOct2b.
The predicted amino acid sequence is shown below the
nucleotide sequence in one letter code. The first in frame
methionine is assigned number 1. The published sequence
of the human Oct2a clone (hOct2a) is shown for
comparison. Identical nucleotides are depicted as dots.
When a base substitution creates a codon for a different
amino acid, the amino acid found in the human protein is
shown below the hOct2a sequence with bold letters. The
48 bp deletion in mOct2b is shown as an insertion after
nucleotide position 717. In this case, the mouse mOct2a
sequence is shown for comparison. In mOct2b, there is a
74 bp insertion after nucleotide position 1568, which creates
a new open reading frame. As a result the carboxy ends
encoded by mOct2b and hOct2a are different. The carboxy
ends encoded by mOct2a and hOct2a will be identical since
there are no nucleotide differences between mouse and
human sequences in this area. At the 3' end of the hOct2a,
small gaps and insertions were allowed in order to maximize
alignment. These differences do not represent differences
between Oct2a and 2b but rather interspecies variations
between mouse and human. The POU-specific and POU
homeo sequences are boxed. The arrows above the mOct2b
sequence indicate the location of exon-intron boundaries
mapped so far as determined by analysis of chromosomal
clones (see also Fig. 4). Note that the arrow after
nucleotide 520 does not represent the first exon-intron
junction since the complete structure of the Oct2 gene is
not known yet. Asterisks indicate the two different stop
codons in mOct2a and mOct2b.
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coding) RNAs, respectively, were synthesized. The firmed that the protein product encoded by mOct2b has
RNAs produced were then translated in vitro using an identical mobility in the EMSA as the complex
rabbit reticulocyte lysates. After translation, the reticu- Oct2b. As shown in Fig. 3, the reticulocyte extract also
locyte extracts were used in the electrophoretic mobility contains endogenous Octl protein. A second complex
shift assay (EMSA) employing a radioactive fragment that runs faster than Oct2a is observed, but this is
from the immunoglobulin heavy chain enhancer which present in both the 'sense' and 'antisense' lanes,
contains the octamer motif (Fig. 3). The results con- The in vitro translation was repeated using radioac-
» 0 c t 2 b AATTCCGCTTTTTTTTTTTTTTTAAATATTTATTTATTTATTATACATAAGTACACTGTAGCTGTCTTCACACACACCAGAAGAGGGACTCAGATCTCATTATGCATGGTTGTGAGCCAC 120
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616 678
Octl SLHPGTLSGALSPALMSNSTVATIQALASGGSLPITSLDATGNLVF ANAGGAPNIVTAPLFLN




Octl PQNLSLLTSNP VSLVSAAAASAGNSAPVASLHATSTSAESIQNSLFTVASASGAASTTTTA SKAE
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
Oct2b HTGLPLLSAPPGVGLVSAAAAAVAASISSKSPGLSSSSSSSSSSTCSDVAAQTPGGPGGPEAGSKAE
517 583
Fig. 2. Amino acid comparison of the carboxy ends of Octl and Oct2b. The last 133 amino acids of Oct2b and the last 128
amino acids of Octl are aligned. Small gaps were introduced in the Octl sequence for maximum alignment. For the
comparison two conservative changes, threonine to serine and leucine to isoleucine were also taken into account.
tive methionine to label the newly synthesized proteins.
After resolving the products in protein-SDS gels, gels
were dried and autoradiographed. The mR4 encoded
protein runs with an apparent MT of approximately
70X103 as predicted (data not shown). Taken together
these results indicate that the protein encoded by the
mOct2b open reading frame is the previously described
OTF-2B factor (Schreiber et al. 1988).
Oct2a and Oct2b are differentially spliced products of
the same gene
Preliminary Southern analysis of human and mouse
chromosomal DNA with the cloned cDNAs as probes
showed that Oct2 is probably a large single copy gene










al. 1988). In addition, apart from the 48bp and 74bp
deletions/insertions, the isolated mouse Oct2 cDNA
clones are identical and colinear with the human
sequences. These data strongly suggest that Oct2a and
Oct2b are differentially spliced products of the same
gene.
In order to confirm this and to see how the different
exons are organized, the structure of the mouse Oct2
gene was analysed in chromosomal clones isolated by
using the synthetic oligonucleotides spanning the hu-
man Oct2 homeobox as a probe. Four independent
overlapping clones were isolated (termed mCRl to 4)
spanning an area of approximately 18 kb. The restric-
tion enzyme map of this area is shown in Fig. 4.
Subcloning, Southern analysis of these clones using
different parts of the cDNAs as probes and sequencing
of the various chromosomal fragments identified 10
exons of the mouse Oct2 gene. It should be noted that
this is not the complete structure of the gene, but simply
the organization of the intron-exon junctions of the
mOct2a and 2b cDNAs from position 520 in the
sequence shown in Fig. 1 to the end. Nevertheless,
the structure of this part of the gene was sufficient at
this point to enable us to explain how the differences
between mOct2a and 2b arise. It is noteworthy that
about 1500 bases of transcribed mRNA sequence are
spread in an area of around 9 kb. The DNA structure of
this part of the gene is characterized by the large
number of exons ranging in size from 67 to more than
550 bp and corresponding introns ranging in size from
75 bp to about 2 kb. The intron-exon organization is
Fig. 3. The insert of clone mR4 encodes the Oct2b octamer
binding protein. RNA from the coding (sense) and non-
coding (antisense) strand of clone mR4 was synthesized in
vitro and then translated in rabbit reticulocyte lysates. The
translation products were then used in the electrophoretic
mobility shift assay (EMSA) with a radioactively labelled
oligonucleotide containing the octamer motif (see Materials
and methods). In the lane, —RNA, the reticulocyte extract
was incubated without addition of exogenous RNA. Sense
and antisense lanes are reticulocyte extracts where the
coding and non-coding RNA strands of the mR4 insert were
translated, respectively. BJA-B is a nuclear extract from a
human mature B-cell line. In —protein lane, the
oligonucleotide was incubated without any extract. The
expected pattern of the BJA-B nuclear extract is observed
and the protein complexes due to Octl, Oct2a and Oct2b
are indicated. F marks the position of the unbound free
oligonucleotide.
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Fig. 4. Partial structure of the mouse Oct2 gene. The restriction map of the 18 kb of the mouse genome that contain part of
the Oct2 gene is shown on top. Below is an expanded area that contains the Oct2 gene exons mapped so far. Arrows with
letters mark the location of restriction sites. B Bg/11; Bm, BamHl; H, Hindlll; K, Kpnl; SI, Sad; S2, Sacll; Sm, Smal.
Restriction sites marked with asterisks are also present in the cDNAs. The exons are denoted by open boxes. The splicing
patterns of mOct2a and mOct2b are shown above and below the exons, respectively. The numbering of 1 to 11 is used for
better visualization of the structure of the mOct2a and 2b transcripts after the differential splicing (shown at the bottom of
the figure). Open rectangles indicate that the structure is incomplete. Black arrowheads above and below exon 11 mark the
location of stop codons in Oct2a and Oct2b transcripts, respectively.
drawn in scale in Fig. 4. The location of the intron-
exon junctions in the cDNAs are shown with arrows in
Fig. 1.
Sequencing of the chromosomal clones shows that
the two differences between mOct2a and mOct2b are
derived as follows (Fig. 4). In the first case, the 48bp
deletion in mOct2b is generated by the use of a second
splice acceptor site 48 bp downstream of the one used in
the case of mOct2a (exon 4 and 3 4, respectively, in
Fig. 4). In both cases, the splice site fits the consensus
mouse sequence (Shapiro and Senapathy, 1987). The
second difference is derived by splicing in mOct2b of an
extra exon (number 10 in Fig. 4) which in the case of
mOct2a is located in the intron area between exons 9
and 11. Thus, although exon 11 is the same in both
transcripts, a different protein is produced since exon 10
shifts the open reading frame of mOct2b. The two
transcripts now use two different stop codons (indicated
by arrowheads in Fig. 4).
Expression of Oct2a and Oct2b
One of the main objectives of this work was to deter-
mine whether the Oct2 gene is expressed in tissues
other than B lymphocytes and in particular during
embryogenesis as was suggested by the EMSA studies
(Scholer et al. 1989a). With the identification of the
novel Oct2b transcript, it also was important to test if
there are differences in the pattern of expression of
Oct2a and Oct2b.
Total RNA was isolated from various tissues, mouse
embryos and cell lines, and the presence of Oct2
transcripts was analysed by using the RNase protection
assay. For this purpose, two probes were used. The first
ontains a 618 bp fragment isolated from the Agtll clone
mR2. This fragment covers the entire POU-specific and
homeoboxes common in both mOct2a and mOct2b
transcripts (fragment F in Fig. 5C, see also Materials
and methods). A prominent band of the expected size is
protected with the mouse B-cell line Ag8 RNA
(Fig. 5A). The same band is protected with RNA from
testis, kidney, intestine, brain, mouse day 12 embryo
and F9 cells. Liver seems negative although a faint band
appears after prolonged film exposures. In testis, an
equally strong band of around 520bp is shown, indi-
cating that an additional transcript exists in testis that
contains a truncated POU-domain. Of all the tissues
tested, B-cells appear to contain the highest amounts of
mOct2a and 2b transcripts, since in this experiment 10
times less B-cell RNA was used compared to the other
tissues.
The probe used in the experiment described in
Fig. 5A cannot distinguish between the mOct2a and
mOct2b transcripts. For this purpose, a second DNA
fragment was used containing the region from the Sad
site in position 1590 to the Nael site at position 1975 of
mOct2b (numbering as in Fig. 1, fragment N in
Fig. 5C). The Sad site is located within the 74 bp
insertion and is not found in mOct2a. As a result, 385 nt
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and 332 nt fragments should be protected by the
mOct2b and mOct2a transcripts, respectively. As
shown in Fig. 5B, two bands of the expected size are
protected, the upper one representing the mOct2b
transcript and the lower one trie mOct2a.
Both transcripts are very abundant in B-cells (again
10 times less RNA was used for the Ag8 lane than in the
other lanes). Interestingly, the ratio of mOct2a to 2b
varies among tissues. mOct2a is more abundant than
mOct2b in B-cells and intestine. In F9 cells and in
• H ^ ^ ^ m0cl2b, 385 nl
+
^•M m0cl2a, 332 nt
kidney, equal amounts of the two transcripts exist. In
testis, day 12 embryo and to some extent in brain, it
appears that mOct2b transcripts are more abundant. At
present, the significance of this observation is unclear.
Several less-intense bands are also protected indicating
that transcripts probably highly homologous but not
identical to Oct2 exist. The fact that the ratio of mOct2a
to 2b varies between tissues and the transcripts are
detected in the F9 cell line rules out the possibility of B
lymphocyte contamination of the RNA preparations.
Fig. 5. Expression of m0ct2a and mOct2b in various
tissues. RNase protection experiments were performed
using total RNA and radioactive antisense RNA probes.
The RNA source is indicated above the lanes. Ag8 is a
mouse B-cell line; F9 is a mouse embryonic
teratocarcinoma cell line. In each case, 40 ng of total RNA
were used except in lane Ag8 where only 4^g were used. In
panel A, the probe is a 720 nt fragment in which 618 nt
covering the POU-domain common in both Oct2a and
Oct2b transcripts are protected (probe F). In panel B the
probe is a 490 nt fragment which contains a 385 nt sequence
from mOct2b (position 1590 to 1975 in Fig. 1; probe N). A
385 nt fragment is protected by the mOct2b transcript and
only a 332 nt fragment by the mOct2a transcript (Upper and
lower arrowheads in panel B). The radioactive marker
shown in the left lane in both A and B is Bluescript plasmid
DNA restricted with Hpall. Panel C is a schematic
representation of the RNase protection experiments shown
in panels A and B. The top line represents the transcript
derived from the Oct2 gene. Broken lines at the two ends
indicate that the complete structure of the 7.5 kb transcript
is not yet known. The arrow denotes the 5' to 3'
orientation. The 48 nt deletion and 74 nt insertion in the
mOct2b clone mR4 are elevated. Numbers above show the
location of the exons as marked in Fig. 4. The solid boxes
in probes F and N represent the Oct2 sequences while the
thin lines represent the presence of Bluescript vector
sequences. The protected fragments are shown as solid
boxes at the bottom, 618 nt for probe F, 385 and 332 nt for
probe N (see also Materials and methods).
Expression of the Oct2 gene during embryogenesis and
in adult brain
The fragment F used in the RNase protection exper-
iment (Fig. 5A) was also used as a probe for in situ
hybridization of mouse day 12 embryo sections.
A Northern blot of BJA-B mRNA probed with
fragment F revealed five transcripts ranging from 1.8 to
7.0 kb (Fig. 6). This is consistent with other analyses of
BJA-B RNA with Oct-2 cDNA probes, hybridizing also
to multiple transcripts in a similiar pattern (Miiller et al.
1988; Staudt et al. 1988; Scheidereit et al. 1988). The
same pattern was also observed when fragment N was
used as a probe (data not shown). This demonstrates
that fragment F does not cross-hybridize with other
POU- and homeobox-genes. Accordingly, fragment F
is an appropiate probe to study the expression of the
Oct-2 gene in mouse embryo as a first step towards
identifying its role in mouse development.
The Oct2 gene is widely expressed in the developing
nervous system (Fig. 7). In particular, expression is
found in the neural tube and in the developing brain,
mainly in diencephalon, mesencephalon, metencepha-
lon and myelencephalon. Interestingly, the expression
level of Oct2 is not homogeneous but stronger in
particular areas. For example, in the' diencephalon,
strong hybridization is observed in the areas where the
optic chiasma and the mammillary bodies will develop,
which corresponds to the observed hybridization in
suprachiasmatic and medial mammillary nuclei in the
adult brain (see below). In addition, reproducible
expression was found in an area running parallel and










Fig. 6. Northern blot analysis of RNA from BJA-B cells
hybridized with fragment F (cDNA probe). 25/Jg of total
RNA (lane 1) and 3.5 ^ g of poly (A)+ RNA (lane 2) were
denatured, seperated on a 1.2% agarose-formaldehyde gel
and blotted with IOXSSC. Hybridization was carried out as
described in Materials and methods. The approximate sizes
of the transcripts are given.
ventrally to the vertebrae in the region of the develop-
ing dorsal aorta, but, at present, this structure has not
been conclusively identified (area marked by arrow-
heads in Fig. 7, panel A).
Although the expression of Oct2 is widespread in the
developing brain, in the adult brain expression is
confined to very small and distinct areas like the medial
mammillary nuclei, the olfactory bulb and tract and the
CA1-CA4 areas of the hippocampus. Very strong
expression was also observed in the suprachiasmatic
nuclei (data not shown). Although piriform cortex
appears positive, hybridization was also observed in the
negative control at a lower level. In addition, ex-
pression is confined only to the CA1-CA4 areas of the
hippocampus. The dentate gyrus appears positive due
to intensive staining by toluidine blue.
Octamer-binding proteins in neuronal and glial cells
While in situ hybridization gives a first indication of
which areas of the brain the Oct2 gene is expressed, it is
not accurate enough to distinguish the cell types that
express the gene. As an initial approach to determine in
which cells Oct2 proteins are present, mixed brain
nuclei were isolated and further fractionated into neur-
onal and glial nuclei. As shown earlier, the nuclear
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Fig. 7. Expression of the Oct2 gene during mouse embryogenesis and in adult brain. Mouse day 12 embryo and adult mouse
brain sections were hybridized with probe F (see Fig. 5C). Left panels A, B, C are dark-field pictures while right panels D,
E, F are the corresponding bright field. (A, D) Sagittal section of mouse day 12 embryo. Arrows point to areas of the
developing nervous system; t, telencephalon; d, diencephalon; ms, mesencephalon; mt, metencephalon; my,
myelencephalon; nt, neural tube. Arrowheads mark the positive area around the dorsal aorta which has not been
conclusively identified. (B, E) Section through adult brain, mn, medial mammillary nuclei; ot, olfactory tract; cp, piriform
cortex; h, hippocampus. Section through the olfactory bulb. Arrows indicate the mitral and granular cell layer (ml).
fractions obtained by this procedure are at least 90 %
pure and are representative of the nuclei of medium-
sized neurons and dark- and medium-type oligodendro-
cytes of rat cerebrum (Stoykova et al. 1985). The
presence of the different octamer-binding proteins was
analysed in the electrophoresis mobility shift assay
using the fragment containing the octamer motif
(Fig. 8). The results show that both cell types contain
the same array of proteins as the whole brain nuclear
extract (Scholere/a/. 1989a). Oct2a is found in both cell
types but is more abundant in glial cells than in neurons.
Octl is present in only very small amounts in neurons.
Oct3 shows the opposite pattern being more abundant
in neuronal than glial cells. Amounts of Oct 8, 9 and 10
are reduced in both cell types.
Discussion
A large number of proteins in tissues, cell lines and












Fig. 8. Distribution of octamer-binding proteins in neuronal
and oligodendroglial cells. A radioactively labelled
oligonucleotide containing the octamer motif was incubated
with 6 jig nuclear extracts from brain, neurons, glial cells,
BJA-B (a human B-cell line) or without extract (—protein
lane). The observed complexes are named on the left side
according to the nomenclature of Sch51er et al. (1989a). F,
free oligonucleotide.
embryos bind to the octamer motif ATTTGCAT (Singh
et al. 1986; Landolfi et al. 1986; Staudt et al. 1986;
Rosales et al. 1987; Scheidereit et al. 1987; Barberis et
al. 1987; Cox et al. 1988; Lenardo et al. 1989; Scholer et
al. 1989a; Scholer et al. 19896). These proteins interact
specifically with this transcriptional regulatory se-
quence since single base exchanges prevent binding
(Staudt et al. 1986; Scholer et al. 1989a). There are
several possibilities about how this large family of
transcriptional factors can be produced. For example,
every one of these proteins might be the product of a
distinct gene. Alternatively, post-transcriptional and
post-translational modifications may give rise to some
of the diversity observed in octamer-binding factors.
While the cloning of Octl and Oct2a showed that these
two are the products of distinct genes (Sturm et al.
1988ft; Ko et al. 1988; Miiller et al. 1988; Scheidereit et
al. 1988; Clerc et al. 1988), the results presented here
demonstrate that two of the octamer-binding proteins,
namely Oct2a and Oct2b, are generated by differential
splicing of the same gene. The cloning of the remaining
factors, Oct3 to OctlO, will reveal their relation to Octl
and Oct2 and whether the third proposed mechanism,
i.e. post-translational modifications, also contributes to
the generation of the family of octamer-binding pro-
teins. Recently, it was shown that a large family of
POU-domain-containing genes exists which could be
placed into four groups (He et al. 1989). These results
demonstrate that, besides the large family of octamer-
binding proteins, other multimember families exist that
bind sequences similar but not identical to the octamer
motif.
The two factors, Oct2a (463 aa) and Oct2b (583 aa),
share common features but also display certain differ-
ences. They have in common the POU-domain respon-
sible for DNA binding and the first 167 amino acids of
the amino terminus containing a glutamine-rich
domain. Oct2b lacks 16 amino acids in the end of this
domain and upstream from the beginning of the POU-
domain (which starts at amino acid 178, Fig. 1). This
deletion occurs because in the mOct2b transcript
another splice acceptor site is used, 48bp downstream
from the one used in mOct2a. This deletion is not
specific for Oct2b since human Oct2a clones have been
isolated that also lack these 16 amino acids (Scheidereit
etal. 1988).
Oct2a and Oct2b also share the 111 amino acids
downstream from the homeo-specific part of the POU-
domain, residues 341 to 451 (Fig. 1). This area contains
the four properly spaced leucines that might be in-
volved in protein-protein homo- and/or heterodimeri-
zations (Landschultz et al. 1988). At this point, there is
a 74 bp insertion in mOct2b which results in a new open
reading frame generating a different carboxy end. This
difference between Oct2a and 2b arises by the splice in
mOct2b of a new exon, which otherwise resides in an
intron of the mOct2a transcript. The carboxy end of
Oct2b is very similar to the one of Octl and they might
have similar functions. Gere et al. have described
another Oct2 transcript which stops after the glycine
residue at position 451 in Fig. 1 (clone 3-1 in Clerc et al.
1988). The sequence that follows in their case is
homologous to the sequence in the mouse intron
following exon 9 in Fig. 4. It seems that this Oct2 gene
transcript includes this intron sequence and a down-
stream splice acceptor site is used.
It is possible that more, presently unidentified, differ-
entially spliced products are derived from the Oct2 gene
which might not be resolved by the two probes used in
the RNase protection experiment. More transcripts,
and consequently more protein products, might be
hidden in the protected bands. In light of this, the RNA
results as well as the in situ hybridization might not
represent specifically Oct2a or Oct2b but the expression
of the Oct2 gene in general. This issue will only be
resolved when the complete array of the Oct2 gene
transcripts is described.
It is interesting that the differential splicing scheme of
the Oct2 gene resembles the patterns seen in the sex-
specific splicing of many Drosophila genes, namely Sxl,
tra and tra-2, which are involved in a hierarchical way in
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sex determination (for a review and references see
Baker, 1989). In this case, downstream acceptor sites or
splicing of additional exons create different transcripts
in males and females. The products of one differential
splice regulate the splicing pattern of the genes below in
the hierarchy. Moreover, the splice in male flies is the
default splicing while the splice pattern in females
requires other proteins which probably interact with the
splicing machinery. It will be interesting to check if
either the mOct2a or the mOct2b splicing pattern is the
default one or if both of them are regulated specifically
by other proteins. Since the ratio of Oct2a to Oct2b is
different in the various tissues, their splicing might be
regulated in a tissue-specific manner.
Differential splicing is also responsible for the gener-
ation of a family of peptides interacting with the
transcriptional regulatory element known as the
CCAATbox (Mermod etal. 1989). Alternate splicing of
the same gene might turn out to be a widespread
mechanism for generating families of related multifunc-
tional regulatory proteins.
It is noteworthy that there is no direct correlation
between the levels of the Oct2 RNAs as detected in the
RNase protection and the levels of Oct2a and Oct2b
binding activities as detected in the EMSA. For
example, while mOct2a and 2b transcripts are found in
F9 cells, no Oct2a and 2b complexes were seen in the
EMSA (Scholer et al. I989a,b). In addition, while the
amount of Oct2a RNA is lower in kidney than in brain
and embryo, the levels of Oct2a complexes are compar-
able in the EMSA (see Fig. 5B and Scholer et al.
1989a). Furthermore, while in brain the amounts of
mOct2a and 2b RNAs are about equal, and in embryos
RNA levels of Oct2b are higher than 2a, no Oct2b
binding is observed in vitro (compare Fig. 5B and
Fig. 8). It is possible that Oct2b does not bind to the
octamer motif as strongly as Oct2a. In addition, appar-
ently other mechanisms operating post-transcription-
ally are responsible for this disrepancy. Alternatively,
proteins like Oct3 to OctlO are differentially spliced
products of the Oct2 gene as well and are responsible
for the protected bands in the RNase protection exper-
iments. Cloning of the remaining octamer-binding pro-
teins will only resolve this issue.
While this manuscript was in preparation, He et al.
also showed in situ hybridization results with an Oct2
probe in embryos and adult brain (He et al. 1989).
Although basically they made the same conclusions,
there are some differences concerning the expression in
adult brain. For example, they did not show expression
in the olfactory bulb and hippocampus, although they
also observed high expression in suprachiasmatic and
medial mammillary nuclei. In addition, they did not see
expression in testis in their RNA analysis. At this point,
we do not have an explanation for these discrepancies
except that different probes and experimental con-
ditions were used.
The EMSA assay shows that Oct2a is present in both
neuronal and glial cells but it is more abundant in glial
cells. Staudt et al. have also observed high levels of
expression of Oct2 in a glioma cell line (Staudt et al.
1988). Eventually, only a specific antibody will provide
a more detailed analysis about the cell types where Oct2
proteins are found. In particular, antibodies that
specifically recognize the different polypeptides will be
essential in describing where the Oct2 proteins are
present. These antibodies could be used to analyse in
more detail the expression pattern of these factors
during mouse embryogenesis and in adult tissues. The
analysis at the protein level will also help to resolve the
discrepancy between the binding activity and the RNA
levels. For example, if protein levels follow the RNA
levels, then binding is regulated post-translationally. If,
on the other hand, the protein levels reflect the binding
pattern, then post-transcriptional and translational con-
trols may be acting.
Octl is involved in cell-cycle regulation of gene
expression as well as in DNA replication. This finding
correlates with high amounts of Octl protein in fast
growing cells (Sturm et al. 1988b). Consequently, it is
interesting that Octl is not present in considerable
amounts in neurons, while its level in glial cells is
comparable to other cell types. Neurons in brain have
lost their ability to divide and do not regenerate after
damage. In contrast, glial cells are able to regenerate,
although they do not divide under normal conditions.
The results presented here indicate that Oct2 pro-
teins play an important role in regulating transcription
in the developing nervous system, adult brain, testis,
kidney and intestine in addition to regulating immuno-
globulin gene expression. The expression of Oct2 gene
in the developing nervous system in embryos correlates
with our previous observation that brain and embryo
nuclear extracts have identical patterns of octamer
complexes in the EMSA (Scholer et al. 1989a). One
prediction of this finding is that the other brain octamer-
binding proteins, namely Oct3 and Oct7 to OctlO, may
be expressed also in the developing embryonic nervous
system.
Future research will need to focus on the function of
the different octamer proteins. It will be interesting to
see if Oct2a and Oct2b are redundant and have the
same function or if they play different roles. The fact
that the octamer motif is found both in promoters close
to the TATA box and in enhancer sequences thousands
of bases away, raises the possibility that one protein,
Oct2a or Oct2b, binds to promoter and the other to
enhancer sequences. Further insights into the regu-
lation of gene expression by this family of transcrip-
tional factors will come from analysis of the mechan-
isms responsible for differential splicing of the Oct2
gene.
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